Evidence map›Paper›PMID 35021194›Full record

Trial reportThe American journal of clinical nutrition2022

The effect of a high-polyphenol Mediterranean diet (Green-MED) combined with physical activity on age-related brain atrophy: the Dietary Intervention Randomized Controlled Trial Polyphenols Unprocessed Study (DIRECT PLUS).

Alon Kaplan, Hila Zelicha, Anat Yaskolka Meir, Ehud Rinott, Gal Tsaban, Gidon Levakov, Ofer Prager, Moti Salti, Yoram Yovell, Jonathan Ofer and 17 more

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of clinical nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03020186 (Effects of Green-MED Diet Via the Gut-fat-brain Axis; DIRECT-PLUS), which is not on this map. Cited by 45 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 3 pooled it
15.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03020186 nacompletednot on this map

Effects of Green-MED Diet Via the Gut-fat-brain Axis; DIRECT-PLUS

TypeinterventionalSponsorBen-Gurion University of the NegevRan2017 to 2019Enrolled294ConditionsAbdominal Obesity Metabolic SyndromeArmsPhysical activity, Physical activity+ MED diet, Physical activity+green MED diet
3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 3 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Oral Supplementation withNutrients · 2025
    Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 7 institutions in 4 countries.

Alon KaplanThe Health & Nutrition Innovative International Research Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Hila ZelichaThe Health & Nutrition Innovative International Research Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Anat Yaskolka MeirThe Health & Nutrition Innovative International Research Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Ehud RinottThe Health & Nutrition Innovative International Research Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.ORCID 0000-0003-3028-5492
Gal TsabanThe Health & Nutrition Innovative International Research Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Gidon LevakovDepartment of Cognitive and Brain Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.ORCID 0000-0002-5520-3556
Ofer PragerZlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Moti SaltiZlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Yoram YovellDepartment of Medical Neurobiology, The Hebrew University-Hadassah School of Medicine, Jerusalem, Israel.
Jonathan OferZlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Sebastian HuhnHelmholtz Centre for Environmental Research (UFZ), Leipzig, Germany.
Frauke BeyerDepartment of Neurology, Max-Planck-Institute for Human Cognitive and Brain Sciences, and Cognitive Neurology, University of Leipzig Medical Center, Leipzig, Germany.
Veronica WitteDepartment of Neurology, Max-Planck-Institute for Human Cognitive and Brain Sciences, and Cognitive Neurology, University of Leipzig Medical Center, Leipzig, Germany.
Arno VillringerDepartment of Neurology, Max-Planck-Institute for Human Cognitive and Brain Sciences, and Cognitive Neurology, University of Leipzig Medical Center, Leipzig, Germany.ORCID 0000-0003-2604-2404
Nachshon MeiranDepartment of Cognitive and Brain Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Tamar B EmeshDepartment of Cognitive and Brain Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Peter KovacsIntegrated Research and Treatment Center (IFB) Adiposity Diseases, Leipzig University Medical Center, Leipzig, Germany.ORCID 0000-0002-0290-5423
Martin von BergenDepartment of Molecular Systems Biology, Helmholtz Centre for Environmental Research (UFZ), Leipzig, Germany.ORCID 0000-0003-4337-7441
Uta CeglarekInstitute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany.ORCID 0000-0002-4034-5535
Matthias BlüherDepartment of Medicine, Leipzig University, Leipzig, Germany.
Michael StumvollDepartment of Medicine, Leipzig University, Leipzig, Germany.
Frank B HuDepartment of Nutrition, Harvard TH Chan School of Public Health, Boston, MA, USA.
Meir J StampferDepartment of Nutrition, Harvard TH Chan School of Public Health, Boston, MA, USA.
Alon FriedmanZlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Ilan ShelefThe Health & Nutrition Innovative International Research Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Galia AvidanDepartment of Cognitive and Brain Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Iris ShaiThe Health & Nutrition Innovative International Research Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Ben-Gurion University of the Negev · ILMax Planck Institute for Human Cognitive and Brain Sciences · DEBrigham and Women's Hospital · USHelmholtz Centre for Environmental Research · DELeipzig University · DEIFB Adiposity Diseases · DEUniversity Hospital Leipzig · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe effect of diet on age-related brain atrophy is largely unproven.

objectivesWe aimed to explore the effect of a Mediterranean diet (MED) higher in polyphenols and lower in red/processed meat (Green-MED diet) on age-related brain atrophy.

methodsThis 18-mo clinical trial longitudinally measured brain structure volumes by MRI using hippocampal occupancy score (HOC) and lateral ventricle volume (LVV) expansion score as neurodegeneration markers. Abdominally obese/dyslipidemic participants were randomly assigned to follow 1) healthy dietary guidelines (HDG), 2) MED, or 3) Green-MED diet. All subjects received free gym memberships and physical activity guidance. Both MED groups consumed 28 g walnuts/d (+440 mg/d polyphenols). The Green-MED group consumed green tea (3-4 cups/d) and Mankai (Wolffia-globosa strain, 100 g frozen cubes/d) green shake (+800 mg/d polyphenols).

resultsAmong 284 participants (88% men; mean age: 51 y; BMI: 31.2 kg/m2; APOE-ε4 genotype = 15.7%), 224 (79%) completed the trial with eligible whole-brain MRIs. The pallidum (-4.2%), third ventricle (+3.9%), and LVV (+2.2%) disclosed the largest volume changes. Compared with younger participants, atrophy was accelerated among those ≥50 y old (HOC change: -1.0% ± 1.4% compared with -0.06% ± 1.1%; 95% CI: 0.6%, 1.3%; P < 0.001; LVV change: 3.2% ± 4.5% compared with 1.3% ± 4.1%; 95% CI: -3.1%, -0.8%; P = 0.001). In subjects ≥ 50 y old, HOC decline and LVV expansion were attenuated in both MED groups, with the best outcomes among Green-MED diet participants, as compared with HDG (HOC: -0.8% ± 1.6% compared with -1.3% ± 1.4%; 95% CI: -1.5%, -0.02%; P = 0.042; LVV: 2.3% ± 4.7% compared with 4.3% ± 4.5%; 95% CI: 0.3%, 5.2%; P = 0.021). Similar patterns were observed among younger subjects. Improved insulin sensitivity over the trial was the parameter most strongly associated with brain atrophy attenuation (P < 0.05). Greater Mankai, green tea, and walnut intake and less red and processed meat were significantly and independently associated with reduced HOC decline (P < 0.05). Elevated urinary concentrations of the polyphenols urolithin-A (r = 0.24; P = 0.013) and tyrosol (r = 0.26; P = 0.007) were significantly associated with lower HOC decline.

conclusionsA Green-MED (high-polyphenol) diet, rich in Mankai, green tea, and walnuts and low in red/processed meat, is potentially neuroprotective for age-related brain atrophy.This trial was registered at clinicaltrials.gov as NCT03020186.

Indexed as

Diet, MediterraneanJuglansAtrophyBrainExerciseFemaleHumansMaleMiddle AgedPolyphenolsTeaPolyphenolsTeaage-related atrophyagingdietary interventionGreen Mediterranean diethippocampal occupancy scoreneurodegenerationpolyphenols

Identifiers

PMID35021194
PMCPMC9071484
OpenAlexW4205893370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.